Concepedia

Publication | Open Access

Efficacy and Safety of Periprocedural Dabigatran in Patients Undergoing Catheter Ablation of Atrial Fibrillation

DOIFull Paper Access

86

Citations

21

References

2012

Year

Kenichi Kaseno, Shigeto Naito, Kohki Nakamura, Tamotsu Sakamoto, Takehito Sasaki, Naofumi Tsukada, Mamoru Hayano, Suguru Nishiuchi, Etsuko Fuke, Yuko Miki,
Circulation Journal

Abstract

Dabigatran at a dose of 110mg twice daily was safe for AF ablation in patients with a relatively low risk of thromboemboli, suggesting that it may become an alternative to warfarin in those patients.

References

YearCitations

Page 1